Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 166
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

The LilBubome - Sequencing LilBub's Magical Genome

LilBub is a magical critter: she's a lovely cat with an extraordinary appearance. Her special traits are...

Do dietary supplements extend lifespan and prevent brain disease?

Can a cheap, over the counter pill, prevent the onset of ageing-related diseases and extend lifespan? I...

New bioactive peptides from skin of a colombian frog

The search for alternative antibiotics is on, due to widespread resistance to current antibiotics. We will...

Backer Badge Funded